Survey
* Your assessment is very important for improving the work of artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the work of artificial intelligence, which forms the content of this project
Diagnostika lymfomů Extranodální lymfomy Doc. MUDr. L. Boudová, Ph. D. Contents WHO Classification 2008 Lymphomas Clonal disorders of lymphoid cells at various stages of differentiation HODGKIN L. Distinction clinical histological NON-HODGKIN L. immature cells (precursors) mature cells Note: B Hodgkin lymphoma is also a (mature)B-cell T lymphoma. Lymphoid malignancies Epidemiology 90%: B; FL+ DLBCL – 60% 4% of all new cancers each year Incidence increasing per 100 000: 34 lymphoid neoplasms Lymphoma diagnosis Sample Lymph node Bone marrow Spleen, extranodal tissue Cerebrospinal fluid Lymphoma diagnosis Histology, cytology Immunohistochemistry Ag detected in tissue slides Molecular biology Clonality, lineage – gene rearrangements Translocation detection, mutations Flow cytometry Clinicopathological correlation, esp. T-cell lymphomas difficult to diagnose Lymphoma diagnosis molecular biology Gene rearrangement (PCR, Southern blot) Clonality and lineage B-cells: IgH T-cells: T-cell antigen receptor Characteristic translocations Mantle cell lymphoma t(11;14) Follicular lymphoma, diffuse large B-cell l. t(14;18) Anaplastic large cell lymphoma t(2;5) Burkitt lymphoma t(8;14) B-cell lymphoma Clonal disorders of B-cells at various stages of differentiation of immature cells - lymphoblasts B-acute lymphoblastic leukaemia - frequent, children B-lymphoblastic lymphoma - rare of mature B-cells most common: diffuse large B-cell lymphoma, follicular; plasma cell myeloma Mature B-cell lymphomas Chronic lymphocytic leukemia/small lymphocytic lymphoma; B-cell prolymphocytic leukemia Lymphoplasmacytic lymphoma Hairy cell leukemia Plasma cell myeloma Monoclonal gammopathy of unknown significance Solitary plasmacytoma of bone Extraosseous plasmacytoma Extranodal marginal zone B-cell lymphoma= MALT Nodal marginal zone B-cell lymphoma Splenic marginal zone lymphoma Mature B-cell lymphomas Follicular lymphoma Mantle cell lymphoma Diffuse large B-cell lymphoma Mediastinal (thymic) large B-cell lymphoma Intravascular large B-cell lymphoma Primary effusion lymphoma Burkitt lymphoma/leukaemia T-cell lymphoma • Precursor T-cell lymphomas - T-acute lymphoblastic leukaemia - T-lymphoblastic lymphoma – Mature T-and NK cell neoplasms • uncommon –10% of all NHL • Most frequent : peripheral T-cell lymphoma, unspecified • large cell anaplastic lymphoma often difficult to diagnose Most common T-cell lymphomas • 1. Leukaemic/disseminated adult T-cell leukaemia - HTLV 1 • 2. cutaneous - mycosis fungoides, Sezary syndrome, primary cut. anaplast. lymphoma • 3. other extranodal - extranod. NK/T - nasal, enteropathy assoc. • 4. nodal - peripheral T-cell lymphoma, NOS, anaplastic large cell lymphoma NK/T-cell lymphoma of nasal type • EBV, angiocentric, destructive • South America, Asia Lethal midline granuloma NK/T-cell l. Wegener granulomatosis Cocaine abuse Diffuse large B-cell lymphoma Diffuse large B-cell lymphoma aggresive, potentially curable COMMON! 1/3 of all lymphomas of adults (med. 64 ys) nodal OR extranodal (1/3) GIT, skin, CNS, testis bone, soft tissue, salivary glands, Waldeyer ring, lung, kidney, liver, spleen, female genital tract Diffuse large B-cell lymphoma Primary OR secondary Chronic lymphocytic leukemia Follicular lymphoma Marginal zone B-cell lymphoma Nodular lymphocyte predom. Hodgkin l. Risk factor: immunodeficiency (often EBV+) Diffuse large B-cell lymphoma Morphologic variants Centroblastic Immunoblastic Plasmablastic DLBCL subtypes T-cell/histiocyte rich CNS Skin- leg type EBV positive - elderly Special lymphomas of large B-cells Mediastinal (thymic) Intravascular Chronic inflammation Lymphomatoid granulomatosis ALK positive plasmablastic Arising in HHV8 Castleman dis. Primary effusion Diffuse large B-cell lymphoma, Giemsa Diffuse large B-cell lymphoma Differential diagnosis Tumors Haematological: lymphomas – peripheral - B, T precursors - B, T myeloid neoplasm Non-haematological: carcinoma, sarcoma, GIST, melanoma, seminoma, glial tumors Reactive disorders: infectious mononucleosis, Kikuchi T-cell /histiocyte rich B-cell lymphoma Diffuse/ vaguely nodular CD20 diffuse large B-cell lymphoma neoplastic B-cells scarce majority reactive T-cells, histiocytes Small B-cells rare BUT areas with increased numbers of small B-cells associated NLPHL ? T-cell /histiocyte rich B-cell lymphoma Differential diagnosis 1. Hodgkin lymphoma - classical - NLPHL (nodular paragranuloma) 2. T-cell lymphoma 3. Reactive disorders – T/HRBCL interfollicular Diffuse large B-cell lymphoma clinicopathological subtypes • mediastinal Mediastinal DLBCL Thymus Female, 30 ys Anterior mediastinal mass Superior vena cava syndrome Clinicopathological differential diagnosis? Mediastinal DLBCL Compartmentalising fibrosis Polymorphic large cells, abundant pale cytoplasm CD20, CD23, CD30, CD45 Mediastinal DLBCL – differential diagnosis Problems 1. small biopsies, crushed cells, small areas for IH 2. background: small ly, eosinophils; RS cells 3. clinicopathological features – med. mass, young woman GRAY ZONE Traverse-Glehen : Mediastinal Gray Zone Lymphoma. The Missing Link Between Classic Hodgkin Lymphoma And Mediastinal Large B-Cell Lymphoma. Am J Surg Pathol, Nov. 2005, 29, 1411-1421 Classical Hodgkin lymphoma Nodular sclerosis Borderline cases BCLUWFIBDLBCLACHL BCLUWFIBDLBCLACHL DLBCL vs. CHL morphology, IHC Garcia, Histopathology 2005 BCLUWFIBDLBCLACHL DLBCL vs. CHL morphology, IHC Traverse-Glehen AJSP 2005 DLBCL Differential diagnosis versus Burkitt lymphoma Burkitt lymphoma 1. endemic (Africa) 2. sporadic (young, rare) 3. immune deficiency-associated - HIV! t(8;14) starry sky BCLUWFIBDLBCLABL BCLUWFIBDLBCLABL DLBCL versus Burkitt morphology, IHC, genetics Chuang AJCP Extranodal lymphomas the primary tumor is extranodal (not nodal) The biggest mass is extranodal at the time of the diagnosis Diagnosis may be nmore difficult than in the LN – other tumours may be more common in extranodal localizations (carcinomas..) – think of the possibility of a lymphoma Most common: GIT, skin, Waldeyer,CNS, testis, bone soft tissue, salivary glands, lung, kidney, liver, spleen, female genital tract Histological types: DLBCL, MALT l. Gastrointestinal lymphomas most common extranodal lymphomas 50% Klinické symptomy často necharakteristické! • pokročilé: tumor v břiše, srůsty kliček, perforace • lymfadenopatie • hepatosplenomegalie • KO: lymfocytóza, LDH • endoskopický nález GI lymphomas Type B DLBCL, MALT MCL, FL T EATL Site Stomach Intestines (ileocaec., jejunum, duodenum) Diffuse large B-cell lymphoma of the stomach DLBCL HE CD20 MALT lymphoma versus DLBCL Gastric DLBCL de novo transformation of a low-grade lymphoma clonal progression in time Independent coexistence of 2 clones: low /high grade component DO NOT USE “HIGH-GRADE MALT LYMPHOMA“ MALT lymphoma stomach, intestine (IPSID) chronic antigenic stimulation - Helicobacter pylori Regulation: specific activated T-cells Slow progression- 90%: stage IE, IIE (bone marrow involvement: rare, 10%) Helicobacter pylori Chronic gastritis Diseases associated with Helicobacter pylori infection • Chronic gastritis • Peptic ulcer • Gastric carcinoma • Gastric MALT lymphoma MALT lymphoma of the stomach MALT lymphoma Different sites common features Architecture Cytology Immunophenotype extrafolik. infiltráty folikulární kolonizace lymfoepiteliální léze monocytoidní, plazmat. buňky Macroscopy: often noncharacteristic Microscopy: Wotherspoon criteria - spectrum 0 normal mucosa 1 chronic active gastritis 2 chronic active gastritis with lymphoid follicles 3 suspicious lymphoid infiltrate, probably reactive 4 suspicious lymphoid infiltrate, probably lymphoma 5 MALT lymphoma MALT lymphoma Immunohistochemistry No specific MALT lymphoma marker Positivity: CD20, CD79a; Ig light chains; Ig heavy chains: IgM; CD43 Negativity: CD5, CD10, bcl6, IgD, cyclin D1 CD21, CD10, Ki-67: residual lymphoid follicles Differential diagnosis of MALT lymphoma HP gastritis Wotherspoon criteria spectrum 0-5 Integrated approach favoring MALT lymphoma: dense lymphoid infiltrate prominent LEL Dutcher bodies infiltration of muscularis mucosae atypia of lymphoid cells B - cell monoclonality other lymphomas: DLBCL, MCL, FL… B-cell monoclonality detection Imunohistochemistry - Ig light chains Molecular biology - PCR - IgH rearrangement Polyclonal IgH rearrangement Monoclonal IgH rearrangement It is often not possible to establish a clear diagnosis in a single biopsy. repeat the biopsy; sampling ? MALT lymphoma/gastritis? Large cell component? Correct diagnosis and treatment Interdisciplinary communication Repeated biopsies, specialized methods MALT lymphoma after therapy • Response: regression of lymphoid infiltrate and LEL • Gastric mucosa: atrophy, intestinal metaplasia, empty, fibrotic, basal lymphoid aggregates • Always assess Helicobacter pylori • B-cell clonality assessment by PCR: not clear Průkaz monoklonality • Imunohistochemie lehké řetězy Ig • Molekulární genetika PCR přestavba genu IgH CDR III Gastric MALT lymphoma Recurrent genetic abnormalities • t(11;18)(q21;q21)/ API2-MALT1 usually the sole genetic abnormality, 25% of g. MALT l., H. p. neg., no response to ATB • t(14;18)(q32;q21)/ IgH-MALT1 non-gastric • t(1;14)(p22;q32)/ IgH-BCL10; t(1;2)(p22;p12) • Different strains of Helicobacter pylori MALT l. in other sites than the stomach • • • • • Eye – Chlamydia psittaci Skin – Borrelia burgdorferi IPSID – Campylobacter jejuni Salivary, thyroid, lung, orbit, breast, skin Localized; disseminated (30%, after a long period) • 5 y OAS: 90% Multiple lymphomatous polyposis Mantle cell lymphoma Follicular lymphoma MALT lymphoma Mantle cell lymphoma Multiple lymphomatous polyposis M60 bad prognosis imunohistochemistry genetics WHO Mantle cell lymphoma - localisation Lymph nodes, Waldeyer; bone marrow Extranodal sites: GIT, skin, others GIT: multiple lymphomatous polyposis (MCL, FL, MALT l.) Mantle cell lymphoma CD5 Cyclin D1 MALT? MCL? FISH t(11;14)(q13;q32) Enteropathy-associated T-cell lymphoma Proximal jejunum Very rare x most common GI T-cell lymphoma Acute abdomen (40%) – emergency surgery Obstruction/perforation, peritonitis, sepsis, death Non-acute: pain, weight loss, malabsorption Age 60, M=F Enteropathy-associated T-cell lymphoma Striking association with celiac disease Histology and immunomorphology Anaplastic/pleomorphic (80%) Celiac dis.+, enteropathy +, CD56Monomorphic (20%) Celiac dis.-, enteropathy+/-, CD56+ Half of the patients die soon after the manifestation Enteropathy-associated T-cell lymphoma CD3 Anaplastic T-cells, plasma cells, eosinophils TCR gamma - PCR ABI PRISM TGGE Testicular lymphomas Lymfomy varlete • Primární x sekundární • 1% všech NHL • 2% nádorů varlete ! nejčastější nádor varlete u mužů 50 let ! I. Dospělí: DLBCL MALT lymfom, folikulární lymfom T-lymfomy T/NK – lymfomy, nosní typ plasmocytom II. Děti: před pubertou Sek. (5% systém.): Burkitt, DLBCL, lymfoblastické nádory Primární: folikulární lymfom Infiltrace varlete parciální celková Zvětšení unilaterální bilat. současné DLBCL Intertubulární růst Destrukce tubulů, difúzní růst Cytologické rysy •Stadium IE Nejčastěji: dif. velkobuněčný B-lymfom - CB, IB - CD20+, CD79a+ Lymfom varlete (DLBCL) ! nejčastější nádor varlete u mužů 50 let ! primární diagnózy: 10% chybné („seminom“) • Většinou diagnostikován v KLIN. ST. IEA • Prognóza nemocných není tak dobrá, jako u odpovídající rizikové skupiny nodálního DLBCL • Pozdních relapsy: CNS, druhostranné varle, zejména u nemocných nedostatečně léčených v úvodu The mysterious link between the brain and the testis CNS lymphomas Primární lymfomy CNS • pouze v CNS • mozek • 1% intrakraniálních nádorů – 1% NHL • imunodeficientní x imunokompetentní MR Multifokální, periventrikulární or unifocal mass Perivask. manžety CD20 RETIKULIN EBV-LMP Predispozice imunitní deficity AIDS Vzácné prezentace lymfomů v NS • Lokalizace Oko Dura mater Mícha, extradurální expanze Lymphomatosis cerebri Kraniální a periferní nervy • Typ lymfomu T-lymfom, ALCL intravask. lymfom SLL, MgZL, FL, PTLD Závěr: primární lymfom CNS svébytná nádorová jednotka histopatologická diagnóza stereotaktická biopsie Intravaskulární B-lymfom Intravaskulární B-lymfom Lymfoproliferace u imunodeficitů immunodeficiencies • Associated tumors • Skin, urogenital tract, lymphomas Stavy se sníženou imunitou 1. iatrogenic immunosuppression after transplantation (posttransplantation lymphoproliferative disease, PTLD) 2. autoimmune diseases (RA, SLE) 3. HIV 4. primary immune deficiencies 5. senile EBV-related B-cell lymphomas PTLD Posttransplantation lymphoproliferative disease Clinicopathological spectrum 1. Histol. Iniciální - časné 2. Polymorfní 3. Monomorfní 4. Hodgkinův lymfom, PTLD podobná Hodgkinově lymfomu Etiopatogeneze • imunosuprese • infekce EBV • chronická antigenní stimulace štěpem • další infekční agens? Vliv EBV Reaktivní T-buňky „IM“ EBV Polymorfní PTLD Polyklonální lymfoidní proliferace Monomorfní PTLD Klonální populace Plazmocytární hyperplazie Klesající imunitní odpověď HL Sekundární genetické změny PTLD – potransplantační lymfoproliferace Early – up to 1 year – EBV - strong role Late – after 1 year • Frekvence PTLD: 1-10% - typ a stupeň imunosuprese, - EBV status • Lokalizace: často extranodální • Nejvíce: 1. rok po transplantaci PTLD časná x pozdní • Mortalita: Tx solidních orgánů: 60% kostní dřeně: 80% • Reverzibilita: u některých PTLD • Původ: příjemce (solidní) x dárce (BMT) EBV • Infectious mononucleosis • Burkitt lymphoma • Hodgkin lymphoma • B-cell lymphomas in immunosuppressed patients (HIV, transplantation) • Nasopharyngeal carcinoma HIV and lymphomas • 1 st most frequent tumor: Kaposi sarcoma • 2nd: lymphomas • Lymphoma - AIDS defining illness • 3% of patients with AIDS Lymfomy u HIV pozitivních lidí agresívní B-lymfomy, často extranodální; heterogenní (GIT, CNS) patogenetické faktory: herpesviry: EBV (v 50%), Kaposi Sarcoma Human Virus/HHV 8 (primary effusion lymphoma) chronická antigenní stimulace genetické abnormality poruchy cytokinové regulace prognóza závisí na tíži imunodeficience Lymphomas associated with HIV Incidence increased: 60-200 x (versus noninfected population) Incidence decreases with HAART, ↑CD4 Hodgkin lymphoma: AIDS: risk 10 x higher Lymfomy u HIV+ 1. lymfomy postihující také imunokompetentní pacienty časté: Burkittův (klasický, plazmacytoidní, atypický) DLBCL (často v CNS!) vzácnější: extranodální B-lymfom z marginální zóny, periferní T-lymfom, klasický Hodgkinův lymfom 2. lymfomy specifické pro HIV+ pacienty primary effusion lymphoma, plazmoblastický lymfom ústní dutiny 3. léze vyskytující se i u jiných imunodeficiencí polymorfní "PTLD" Lymfoproliferativní choroby u primárních imunodeficiencí • • • • • • • • rare More than 60 PID Heterogenous Manifestattion highly variable Ataxia teleangiectasia Wiskott Aldrich sy CVID SCID XLP… Lymfoproliferativní choroby u primárních imunodeficiencí hlavně u dětí, častěji u chlapců; (x common variable immunodeficiency: dospělí) většinou extranodální (GIT, CNS) většinou B-lymfoproliferace: fatální infekční mononukleóza, DLBCL, lymfomatoidní granulomatóza, Hodgkinův lymfom; T-lymfomy /leukémie Oyama AJSP 2003 Senile EBV+ lymphoproliferations no other overt ID, only the age… EBV + senile lymphoproliferations • • • • Rare Asia over 50 Various histological appearance